Results 211 to 220 of about 216,339 (397)

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema [PDF]

, 2007
J. Fernando Arévalo, Jans Fromow-Guerra, Hugo Quiroz–Mercado, J. García Sánchez, Lihteh Wu, Maurício Maia, María H. Berrocal, A. Solis–Vivanco, Michel Eid Farah   +8 more
openalex   +1 more source

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.

New England Journal of Medicine, 2007
K. Miller, Molin Wang, J. Gralow, M. Dickler, M. Cobleigh, E. Perez, T. Shenkier, D. Cella, N. Davidson   +8 more
semanticscholar   +1 more source

Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown, Graham Meredith, Bo Gao, Pei Ding, Harriet Gee, Inês Pires da Silva, Adnan Nagrial, Eric Hau   +7 more
wiley   +1 more source

Efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients: a retrospective, comparative study

World Journal of Surgical Oncology
Objective The clinical benefits of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients are controversial. This study intended to evaluate the efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in these ...
Bin Yin, Wei Luo
doaj   +1 more source

Press Release: Chemotherapy with Bevacizumab Increases Risk of Blood Clots in Arteries [PDF]

, 2007
L. Savage, Andrea Widener
openalex   +1 more source

Comparative efficacy of intravitreal anti‐VEGF therapy for neovascular age‐related macular degeneration: A systematic review with network meta‐analysis

Acta Ophthalmologica, EarlyView.
Abstract The aim of this review was to evaluate the comparative efficacy of intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy for neovascular AMD. We searched 12 literature databases for randomised clinical trials (RCT) on anti‐VEGF therapy for neovascular AMD and extracted data on: change from baseline to 12 months in best ...
Emilie T. S. Butler, Andreas Arnold‐Vangsted, Marianne G. Schou, Rodrigo Anguita, Jakob Bjerager, Enrico Borrelli, Lasse J. Cehofski, Lorenzo Ferro Desideri, Elon H. C. van Dijk, Carsten Faber, Jakob Grauslund, Javad N. Hajari, Josef Huemer, Oliver N. Klefter, Marie Krogh Nielsen, M. Cem Sabaner, Miklos Schneider, Yousif Subhi   +17 more
wiley   +1 more source

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme [PDF]

, 2007
James J. Vredenburgh, Annick Desjardins, James E. Herndon, Jennifer Marcello, David A. Reardon, Jennifer A. Quinn, Jeremy N. Rich, Sith Sathornsumetee, Sridharan Gururangan, John H. Sampson, Melissa Wagner, Leighann Bailey, Darell D. Bigner, Allan H. Friedman, Henry S. Friedman   +14 more
openalex   +1 more source

A randomized trial of bevacizumab for newly diagnosed glioblastoma.

New England Journal of Medicine, 2014
M. Gilbert, J. Dignam, T. Armstrong, J. Wefel, D. Blumenthal, M. Vogelbaum, H. Colman, A. Chakravarti, S. Pugh, M. Won, R. Jeraj, P. Brown, K. Jaeckle, D. Schiff, V. Stieber, D. Brachman, M. Werner-Wasik, I. Tremont-Lukats, E. Sulman, K. Aldape, W. Curran, M. Mehta   +21 more
semanticscholar   +1 more source

Intravitreal anti‐vascular endothelial growth factor injections and risks of stroke in patients with neovascular age‐related macular degeneration—A registry‐based cohort study

Acta Ophthalmologica, EarlyView.
Abstract Background Intravitreal Anti‐Vascular Endothelial Growth Factor (VEGF) rescues retinal vasculatures and prevents disease progression in patients with neovascular Age‐Related Macular Degeneration (nAMD). However, systemic anti‐VEGF may increase the risk of thromboembolic related complications including stroke and TIA. This study aims to explore
A. H. Falemban, K. Söderberg‐Löfdal, F. Jonsson, S. Almlöf‐Sarman, M. von Euler, I. Westborg   +5 more
wiley   +1 more source

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma [PDF]

, 2007
James J. Vredenburgh, Annick Desjardins, James E. Herndon, Jeannette M. Dowell, David A. Reardon, Jennifer A. Quinn, Jeremy N. Rich, Sith Sathornsumetee, Sridharan Gururangan, Melissa Wagner, Darell D. Bigner, Allan H. Friedman, Henry S. Friedman   +12 more
openalex   +1 more source